Discovery and Evaluation of Polymorphisms in the and Promoter Regions for Risk of Korean Lung Cancer

AKT is a signal transduction protein that plays a central role in the tumorigenesis. There are 3 mammalian isoforms of this serine/threonine protein kinase-AKT1, AKT2, and AKT3-showing a broad tissue distribution. We first discovered 2 novel polymorphisms (AKT2 -9826 C/G and AKT3 -811 A/G), and we c...

Full description

Saved in:
Bibliographic Details
Main Authors: Jae Sook Sung, Kyong Hwa Park, Seung Tae Kim, Yeul Hong Kim
Format: Article
Language:English
Published: BioMed Central 2012-09-01
Series:Genomics & Informatics
Subjects:
Online Access:http://genominfo.org/upload/pdf/gni-10-167.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832569164696387584
author Jae Sook Sung
Kyong Hwa Park
Seung Tae Kim
Yeul Hong Kim
author_facet Jae Sook Sung
Kyong Hwa Park
Seung Tae Kim
Yeul Hong Kim
author_sort Jae Sook Sung
collection DOAJ
description AKT is a signal transduction protein that plays a central role in the tumorigenesis. There are 3 mammalian isoforms of this serine/threonine protein kinase-AKT1, AKT2, and AKT3-showing a broad tissue distribution. We first discovered 2 novel polymorphisms (AKT2 -9826 C/G and AKT3 -811 A/G), and we confirmed 6 known polymorphisms (AKT2 -9473 C/T, AKT2 -9151 C/T, AKT2 -9025 C/T, AKT2 -8618G/A, AKT3 -675 A/-, and AKT3 -244 C/T) of the AKT2 and AKT3 promoter region in 24 blood samples of Korean lung cancer patients using direct sequencing. To evaluate the role of AKT2 and AKT3 polymorphisms in the risk of Korean lung cancer, genotypes of the AKT2 and AKT3 polymorphisms (AKT2 -9826 C/G, AKT2 -9473 C/T, AKT2 -9151 C/T, AKT2 -9025 C/T, AKT2 -8618G/A, and AKT3 -675 A/-) were determined in 360 lung cancer patients and 360 normal controls. Statistical analyses revealed that the genotypes and haplotypes in the AKT2 and AKT3 promoter regions were not significantly associated with the risk of lung cancer in the Korean population. These results suggest that polymorphisms of the AKT2 and AKT3 promoter regions do not contribute to the genetic susceptibility to lung cancer in the Korean population.
format Article
id doaj-art-0339f5e404e74935820811ff460d46ab
institution Kabale University
issn 1598-866X
2234-0742
language English
publishDate 2012-09-01
publisher BioMed Central
record_format Article
series Genomics & Informatics
spelling doaj-art-0339f5e404e74935820811ff460d46ab2025-02-02T22:50:59ZengBioMed CentralGenomics & Informatics1598-866X2234-07422012-09-0110316717410.5808/GI.2012.10.3.16710Discovery and Evaluation of Polymorphisms in the and Promoter Regions for Risk of Korean Lung CancerJae Sook Sung0Kyong Hwa Park1Seung Tae Kim2Yeul Hong Kim3Genomic Research Center for Lung and Breast/Ovarian Cancers, Korea University Anam Hospital, Seoul 136-705, Korea.Division of Oncology/Hematology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul 136-701, Korea.Division of Oncology/Hematology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul 136-701, Korea.Genomic Research Center for Lung and Breast/Ovarian Cancers, Korea University Anam Hospital, Seoul 136-705, Korea.AKT is a signal transduction protein that plays a central role in the tumorigenesis. There are 3 mammalian isoforms of this serine/threonine protein kinase-AKT1, AKT2, and AKT3-showing a broad tissue distribution. We first discovered 2 novel polymorphisms (AKT2 -9826 C/G and AKT3 -811 A/G), and we confirmed 6 known polymorphisms (AKT2 -9473 C/T, AKT2 -9151 C/T, AKT2 -9025 C/T, AKT2 -8618G/A, AKT3 -675 A/-, and AKT3 -244 C/T) of the AKT2 and AKT3 promoter region in 24 blood samples of Korean lung cancer patients using direct sequencing. To evaluate the role of AKT2 and AKT3 polymorphisms in the risk of Korean lung cancer, genotypes of the AKT2 and AKT3 polymorphisms (AKT2 -9826 C/G, AKT2 -9473 C/T, AKT2 -9151 C/T, AKT2 -9025 C/T, AKT2 -8618G/A, and AKT3 -675 A/-) were determined in 360 lung cancer patients and 360 normal controls. Statistical analyses revealed that the genotypes and haplotypes in the AKT2 and AKT3 promoter regions were not significantly associated with the risk of lung cancer in the Korean population. These results suggest that polymorphisms of the AKT2 and AKT3 promoter regions do not contribute to the genetic susceptibility to lung cancer in the Korean population.http://genominfo.org/upload/pdf/gni-10-167.pdfAKTgenetic polymorphismgenetic promoter regionlung neoplasms
spellingShingle Jae Sook Sung
Kyong Hwa Park
Seung Tae Kim
Yeul Hong Kim
Discovery and Evaluation of Polymorphisms in the and Promoter Regions for Risk of Korean Lung Cancer
Genomics & Informatics
AKT
genetic polymorphism
genetic promoter region
lung neoplasms
title Discovery and Evaluation of Polymorphisms in the and Promoter Regions for Risk of Korean Lung Cancer
title_full Discovery and Evaluation of Polymorphisms in the and Promoter Regions for Risk of Korean Lung Cancer
title_fullStr Discovery and Evaluation of Polymorphisms in the and Promoter Regions for Risk of Korean Lung Cancer
title_full_unstemmed Discovery and Evaluation of Polymorphisms in the and Promoter Regions for Risk of Korean Lung Cancer
title_short Discovery and Evaluation of Polymorphisms in the and Promoter Regions for Risk of Korean Lung Cancer
title_sort discovery and evaluation of polymorphisms in the and promoter regions for risk of korean lung cancer
topic AKT
genetic polymorphism
genetic promoter region
lung neoplasms
url http://genominfo.org/upload/pdf/gni-10-167.pdf
work_keys_str_mv AT jaesooksung discoveryandevaluationofpolymorphismsintheandpromoterregionsforriskofkoreanlungcancer
AT kyonghwapark discoveryandevaluationofpolymorphismsintheandpromoterregionsforriskofkoreanlungcancer
AT seungtaekim discoveryandevaluationofpolymorphismsintheandpromoterregionsforriskofkoreanlungcancer
AT yeulhongkim discoveryandevaluationofpolymorphismsintheandpromoterregionsforriskofkoreanlungcancer